Serum IgG anti-GM1 antibodies have been reported to occur in a variety
of disorders, including Guillain-Barre syndrome and chronic polyneuro
pathies. Of over 5,000 serums tested in our laboratory, high titers of
selective IgG anti-GM1 antibodies (>1:1,000) and without binding to s
ulfatide Fc ere found in 35 patients. Clinical correlation revealed th
at almost all patients had axonal, motor neuropathies. One subgroup wa
s comprised of individuals with an acute motor neuropathy, described e
ither as an acute axonal Guillain-Barre-like syndrome that was occasio
nally associated with a prodrome of Campylobacter jejuni enteritis or
as Chinese paralysis syndrome. A second group of patients had chronic
asymmetric lower motor neuron (LMN) syndromes with no conduction block
or other evidence of demyelination. The presence of selective high-ti
ter IgG anti-GM1 antibody reactivity in serum is uncommon but when pre
sent is strongly associated with acute axonal motor neuropathies or ch
ronic asymmetric LMN syndromes.